mHealth ElectroNic COnsultation REcording (mENCORE) in Advanced Prostate Cancer

Completed · Not applicable

Conditions studied: Metastatic Prostate Cancer

In brief

Patients surviving with advanced prostate cancer frequently encounter time points in their disease course that require choosing among multiple options regarding systemic therapy. Interventions to improve shared decision-making through patient support measures such as question listing, and audio recording and summarizing of consultations have been shown to improve patient-reported measures of decision making quality, e.g. decreased decisional conflict and regret. However, the feasibility of consultation recording and summarizing with mobile health (mHealth) technology on patient-owned smartphones is unknown. The investigators will conduct a single-arm trial to determine feasibility and acceptability of a clinician-prompted, patient administered smartphone audio recording application and a service to summarize the recordings (Patient Support Corps or PSC), in improving decision-making quality among patients with chemotherapy-naive, progressive, metastatic castration-resistant prostate cancer (mCRPC). This trial will inform the design and conduct of a larger trial evaluating broader scale implementation of this intervention.

Key facts

Study ID

NCT04545697

Run by

University of California, San Francisco

People needed

27

Starts

2020-09-18

Expected to finish

2021-02-28

Last updated by the study team

2021-06-01

Who can join

Age: 18 and older. Sex: male. Healthy volunteers: not accepted.

You may qualify if…

• Prostate cancer of any histology.
• Metastatic castrate-resistant Prostate Cancer (mCRPC)
• Progression per any Prostate Cancer Working Group 3(PCWG3) criterion.
• Has never received chemotherapy
• Currently receiving or has previously received any androgen-signaling inhibitors (ASI) (abiraterone, enzalutamide, apalutamide, or darolutamide) that was discontinued due to progression
• 18 years of age or older.
• Able to read, speak, and write in English.
• Has an upcoming genitourinary (GU) medical oncology appointment (in-person or Zoom video visit) at University of California, San Francisco (UCSF) within 7-60 days of enrollment.
• Has access to and ability to use an iPhone (iOS) or Android smartphone.
• Patient's UCSF oncology provider agrees to be recorded.

You may not qualify if…

• Lack of decision-making capacity to provide consent to this trial.
• Uncorrectable hearing or visual impairment hindering the ability to perform necessary tasks in the trial.
• Any neurocognitive or psychiatric disorder hindering the ability to perform necessary tasks in the trial.

Where it is running

• University of California, San Francisco — San Francisco, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.